Strategies in Crohn's disease treatment - "step-up" vs. "top-down"
Inflammatory bowel diseases (IBD) are chronic conditions that lead to serious complications and act to the detriment of quality of patients' lives. Etiology of IBD has not been precisely determined but it is assumed that IBD is caused by genetic, immune and environmental factors. The main target in current IBD treatment is the induction and maintenance of remission. The most common strategy in IBD therapy is called "step-up" that is based on gradual introduction of stronger drugs. However, the latest research shows that "top down" strategy is more promising and can change the natural course of the disease. The aim of this article is to discuss both strategies and compare their effectiveness.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Postepy biochemii - 65(2020), 4 vom: 04. Jan., Seite 313-317 |
| Sprache: |
Polnisch |
|---|
| Weiterer Titel: |
Postępowanie w chorobie Leśniowskiego-Crohna – step-up czy top-down? |
|---|
| Beteiligte Personen: |
Piotrowska, Marta [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.02.2020 Date Revised 03.02.2020 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.18388/pb.2019_288 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305435949 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305435949 | ||
| 003 | DE-627 | ||
| 005 | 20231225121159.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||pol c | ||
| 024 | 7 | |a 10.18388/pb.2019_288 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1018.xml |
| 035 | |a (DE-627)NLM305435949 | ||
| 035 | |a (NLM)31945286 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a pol | ||
| 100 | 1 | |a Piotrowska, Marta |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Strategies in Crohn's disease treatment - "step-up" vs. "top-down" |
| 246 | 3 | 3 | |a Postępowanie w chorobie Leśniowskiego-Crohna – step-up czy top-down? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.02.2020 | ||
| 500 | |a Date Revised 03.02.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Inflammatory bowel diseases (IBD) are chronic conditions that lead to serious complications and act to the detriment of quality of patients' lives. Etiology of IBD has not been precisely determined but it is assumed that IBD is caused by genetic, immune and environmental factors. The main target in current IBD treatment is the induction and maintenance of remission. The most common strategy in IBD therapy is called "step-up" that is based on gradual introduction of stronger drugs. However, the latest research shows that "top down" strategy is more promising and can change the natural course of the disease. The aim of this article is to discuss both strategies and compare their effectiveness | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Krajewska, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Fichna, Jakub |e verfasserin |4 aut | |
| 700 | 1 | |a Majchrzak, Kinga |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Postepy biochemii |d 1954 |g 65(2020), 4 vom: 04. Jan., Seite 313-317 |w (DE-627)NLM000034541 |x 0032-5422 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2020 |g number:4 |g day:04 |g month:01 |g pages:313-317 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18388/pb.2019_288 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2020 |e 4 |b 04 |c 01 |h 313-317 | ||